NCT05967559

Brief Summary

Cancer is one of the major health problems facing Turkey and the world. One of the methods used to treat cancer is chemotherapy. During this treatment period, some side effects may develop in patients. These developing symptoms can be managed with effective nursing interventions, which in turn can increase the patient's quality of life. Managing these symptoms is among the responsibilities of the nurse. The nurses' ability to effectively manage the side effects of chemotherapy depends on gaining specific knowledge, attitudes, and skills during their vocational training and the development of problem-solving and critical thinking. The research was carried out to examine the effect of chemotherapy symptom management education based on the online flipped learning model on the achievement, critical thinking, and self-directed learning of nursing students.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2021

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

July 12, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

1.6 years

First QC Date

July 12, 2023

Last Update Submit

July 21, 2023

Conditions

Keywords

academic achievementchemotherapycritical thinkingonline learningnursing studentsactive learning

Outcome Measures

Primary Outcomes (1)

  • Chemotherapy Symptom Management Knowledge Test (CSMKT)

    The Chemotherapy Symptom Management Knowledge Test (CSMKT) was developed by the researchers to evaluate the impact of chemotherapy symptom management training based on the online flipped learning model. The measurement tool was presented to the expert opinion. Necessary corrections were made in accordance with the views of the experts and validity and reliability analyzes were carried. The test consists of 25 questions with a total of five options.The minimum score that can be attainable from the scale is 0, and the maximum score is 100. As the total score increases, the academic success of the student increases.

    1 month

Secondary Outcomes (2)

  • Marmara Critical Thinking Dispositions Scale (MCTDS)

    1 month

  • Self-Directed Learning Skills Scale (SDLSS)

    1 month

Study Arms (2)

Experiment group

EXPERIMENTAL

The experimental group received online flipped learning training for six weeks.

Other: Online Flipped Learning Group

Control groups

OTHER

The control group received traditional learning training for 6 weeks.

Other: Traditional learning Group

Interventions

The experimental group is the group that receives online flipped learning training.

Experiment group

The control group is the group that received traditional learning training.

Control groups

Eligibility Criteria

Age19 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Second-year students who took the course basics of nursing, internal medicine nursing, physiology, pathology, and computer courses and were able to actively use the computer and voluntarily participated in the research were included.

You may not qualify if:

  • Students in other classes
  • Those who did not volunteer to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tekirdağ Namık Kemal University

Tekirdağ, 59400, Turkey (Türkiye)

Location

Study Officials

  • Dilek Erden, PhD.

    Namik Kemal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The aim of the research was to reduce the bias by using a single-blind technique.
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: The students who were informed about the research, and after obtaining their individual consent, the Chemotherapy Symptom Management Knowledge Test , the Marmara Critical Thinking Dispositions Scale , and the Self-Directed Learning Skills Scale were administered using an online questionnaire. Chemotherapy symptom management training was conducted online for six weeks, one hour per week, for experiment and control groups. The research began with the control group to minimize the interaction between the students in the experiment and control groups. Then the experiment group practices were carried out after the control group's program was completed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator Dr.

Study Record Dates

First Submitted

July 12, 2023

First Posted

August 1, 2023

Study Start

January 10, 2020

Primary Completion

July 29, 2021

Study Completion

July 1, 2022

Last Updated

August 1, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations